SCHEMBL1344183

SCHEMBL1344183

CCOC(=O)Cc1ccc(Cl)c(Oc2cc(C#N)cc(CC)c2)c1F

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RORC P51449 1/20 0.35
GPR35 Q9HC97 1/20 0.34
F10 P00742 1/20 0.34
KCNH2 Q12809 3/20 0.34
EPAS1 Q99814 1/20 0.34
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PDE5A O76074 1/20 0.33
MDM2 Q00987 2/20 0.33
TP53 P04637 1/20 0.33
S1PR1 P21453 1/20 0.33
PGR P06401 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1342509 0.93 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19RORCGPR35
SCHEMBL13983342 0.90 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19RORCGPR35
SCHEMBL12130348 0.90 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19RORCGPR35
SCHEMBL1344905 0.90 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19RORCGPR35
SCHEMBL12132023 0.90 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19RORCF10
SCHEMBL16175564 0.89 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19RORCKCNH2
SCHEMBL1343942 0.88 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19RORCGPR35
SCHEMBL1341700 0.87 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19RORCGPR35
SCHEMBL5373280 0.87 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19RORCGPR35
SCHEMBL1344314 0.87 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19RORCGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063028-B2 Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (US) 2011-11-22 US disclosed
US-8063064-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2011-11-22 US disclosed
EP-2057125-B1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2011-03-30 EP disclosed